Advances In Bioprocessing For Biologics And Gene Therapy Vectors

By Jeremy Petravicz, R. Sharma, S.T.L. Harrison and S.L. Tai, S. Gopal, A.E. Osborne, L. Hock et al., E. Csaszar, S. Mills and P.W. Zandstra, E. Puente-Massaguer, I. González-Domínguez, F. Strobl et al., J.L. Escobar Ivirico and M. Sha

Bioprocessing is the development and manufacturing of therapeutic agents, such as engineered recombinant proteins, viral gene therapy vectors, and other nanoparticle-based technologies. Advances in bioprocessing have the potential to revolutionize the development of next generation therapies and personalized medicine, as well as vaccines for emerging infectious diseases. For example, vaccine development that focuses on the use of engineered virus-like particles (VLPs) has recently shown significant promise as a platform. Continued research and development in bioprocessing has the potential to significantly improve the lives of patients around the world.

The goal of this article collection is to present some of those recent advances for biologics and gene therapy vectors. The authors cover various topics from modern medicine to novel foods.